Capital expenditure · 2011–2025
Elite Pharmaceuticals capital expenditure
$925,626−43.0% · FY2025
Elite Pharmaceuticals (ELTP) reported $925,626 in capital expenditure for fiscal 2025, −43.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252026-03-31 | $925,626 | −43.0% | Open → |
| FY20242025-03-31 | $1.6M | +100.7% | Open → |
| FY20232024-03-31 | $809,653 | −85.9% | Open → |
| FY20222023-03-31 | $5.7M | +1,050.6% | Open → |
| FY20212022-03-31 | $498,566 | +18.7% | Open → |
| FY20142015-03-31 | $419,887 | +794.4% | Open → |
| FY20132014-03-31 | $46,945 | +40.1% | Open → |
| FY20122013-03-31 | $33,519 | −92.0% | Open → |
| FY20112012-03-31 | $421,556 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +5.8%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/elite-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001493152-26-031070 · June 29, 2026
{{cite web |title=Elite Pharmaceuticals capital expenditure — 10-K (0001493152-26-031070) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226031070/form10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.